socalTECH

OCTOBER 30, 2019

Pasadena-based Green Dot and Walmart said on Monday afternoon that they have created a fintech accelerator, as part of an extended relationship. According to the two, Green Dot will continue to serve as the issuing bank and program manager for the Walmart MoneyCard program for an additional period of seven years. Green Dot has been managing Walmart's MoneyCard program since 2006.

Pasadena 100

Pasadena Services Develop Development 100

SoCal Tech Calendar

OCTOBER 30, 2019

Tuesday, November 5, 2019 -- Preccelerator Workshop: Employment Law for Startups with Rachael Lavi. Rachael Lavi, an Attorney specializing in Labor and Employment matters in California, will be speaking on the top employment law risks for startup companies in California, including: (1) best practices for hiring employees; (2) independent contractors and misclassification issues; (3) how to utilize interns; and other significant legal risks.

Startup 100

Startup Company Companies 100

Startup Professionals Musings

OCTOBER 30, 2019

By default, every one of you who owns a business or manages a team has the title of leader, but in my consulting experience, I find that just having the title doesn’t make most of us a leader. I also find that leaders are made, not born , meaning that we all can grow into leadership, if we learn from experience. I find also that if you fail as a leader, your team will likely fail with you.

Course 78

Course Coach Mentor Training 78

SoCal Tech Calendar

OCTOBER 30, 2019

Tuesday, November 5, 2019 -- Preccelerator Workshop: Employment Law for Startups with Rachael Lavi. Rachael Lavi, an Attorney specializing in Labor and Employment matters in California, will be speaking on the top employment law risks for startup companies in California, including: (1) best practices for hiring employees; (2) independent contractors and misclassification issues; (3) how to utilize interns; and other significant legal risks.

Startup 100

Startup Company Companies 100

Advertiser: Aggregage

Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.

Company

Xconomy

OCTOBER 30, 2019

Novartis must stop enrollment of a clinical trial testing its gene therapy for a rare, muscular disorder after safety concerns surfaced in data from an animal study. The FDA put a partial clinical hold on a Phase 1/2 study testing the therapy, Zolgensma, Novartis (NYSE: NVS ) announced Wednesday. The decision doesn’t halt the study entirely; it means that no new patients can be added.

Study 49

Study San Diego Blogging 49